Most emerging markets (EMs), including India, have experienced volatility ahead of Donald Trump's second term. However, ...

Catalyst Pharmaceuticals settles patent litigation with Teva, delaying generic Firdapse launch until 2035. Legal actions against other defendants remain ongoing.

Despite weathering significant criticism from lawmakers and patient groups over the steep cost of its rare disease med ...

On Wednesday, Catalyst Pharmaceuticals Inc. (NASDAQ ... If approved by the FDA, Teva will not market its generic version of Firdapse in the United States before February 25, 2035, unless certain ...

It wasn't just fact-checking that Meta scrapped from its platforms as it prepares for the second Trump administration. Meta ...

I expect it to be a powerful catalyst for the share price because ... Additionally, geopolitical tensions, particularly between the United States and China, could disrupt global supply chains ...

The now-deleted sentence said that hate speech “creates an environment of intimidation and exclusion, and in some cases may promote ... not only in the United States where there has been an ...

Bezuclastinib's upcoming data in July 2025 could be a game-changer for COGT, offering a lucrative investment opportunity. See ...

We trust that is the case. The underlying message of the museum ... But if you’d told us on New Year’s Day that we’d be seeing some of the most beautiful neighborhoods in Los Angeles burn ...

Meta CEO Mark Zuckerberg said Tuesday that the company will “remove restrictions on topics like immigration and gender that are out of touch with mainstream discourse,” citing “recent elections” as a ...

BOSTON, MA / ACCESSWIRE / January 9, 2025 / MassRobotics announces the fourth cohort of its Healthcare Robotics Startup Catalyst Program ... in supporting their US market entry initiatives ...